Barely Significant
← all excerpts

Investigation of betaine as a novel psychotherapeutic for schizophrenia.

EBioMedicine · 2019 · PMC6642071 · PMID 31255657

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

showed a trendp < 0.1so close (0.05 < p ≤ 0.1)
In the plasma, homocysteine concentration was increased by the disruption of Chdh ( p < 0.01), and it showed a trend towards WT level ( p < 0.1) upon betaine supplementation ( Fig. 2 f).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.